PL2305238T3 - N-acetylo-L-cysteina do leczenia endometriozy - Google Patents

N-acetylo-L-cysteina do leczenia endometriozy

Info

Publication number
PL2305238T3
PL2305238T3 PL09171394T PL09171394T PL2305238T3 PL 2305238 T3 PL2305238 T3 PL 2305238T3 PL 09171394 T PL09171394 T PL 09171394T PL 09171394 T PL09171394 T PL 09171394T PL 2305238 T3 PL2305238 T3 PL 2305238T3
Authority
PL
Poland
Prior art keywords
treatment
endometriosis
nac
reduce
cysteine
Prior art date
Application number
PL09171394T
Other languages
English (en)
Inventor
Tiziana Parasassi
Maria Grazia Porpora
Original Assignee
Iasomai Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iasomai Ab filed Critical Iasomai Ab
Publication of PL2305238T3 publication Critical patent/PL2305238T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
PL09171394T 2009-09-25 2009-09-25 N-acetylo-L-cysteina do leczenia endometriozy PL2305238T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09171394A EP2305238B1 (en) 2009-09-25 2009-09-25 N-acetyl-L-cysteine for the treatment of endometriosis

Publications (1)

Publication Number Publication Date
PL2305238T3 true PL2305238T3 (pl) 2012-07-31

Family

ID=41396460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09171394T PL2305238T3 (pl) 2009-09-25 2009-09-25 N-acetylo-L-cysteina do leczenia endometriozy

Country Status (11)

Country Link
US (1) US8637573B2 (pl)
EP (1) EP2305238B1 (pl)
JP (1) JP5699396B2 (pl)
CN (3) CN107007584A (pl)
AT (1) ATE536870T1 (pl)
AU (1) AU2010299801B2 (pl)
DK (1) DK2305238T3 (pl)
ES (1) ES2382167T3 (pl)
PL (1) PL2305238T3 (pl)
RU (1) RU2549433C2 (pl)
WO (1) WO2011036265A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305238B1 (en) 2009-09-25 2011-12-14 Iasomai aktiebolag N-acetyl-L-cysteine for the treatment of endometriosis
WO2012130646A1 (en) 2011-03-25 2012-10-04 Iasomai Ab N-acetyl-l-cysteine for the treatment of dysmenorrhea
CN103608006B (zh) 2011-04-01 2017-07-07 伊亚索梅股份公司 包含n‑乙酰基‑l‑半胱氨酸的组合及其用途
CN104768614B (zh) 2012-11-09 2019-05-03 伊亚索梅股份公司 N-乙酰基-l-半胱氨酸在制备治疗体外受精药物中的用途
EP2789345A1 (en) * 2013-04-09 2014-10-15 Pizeta Group S.r.l. Composition for the treatment of endometriosis
CN104856996B (zh) * 2015-04-27 2018-01-05 南京舒鹏生物科技有限公司 吡咯喹啉醌、其衍生物和/或盐新的药用用途以及药用组合物
RU2597845C1 (ru) * 2015-06-25 2016-09-20 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ улучшения рецептивности эндометрия у пациенток с бесплодием, ассоциированным с эндометриозом
CN110151783A (zh) * 2019-02-02 2019-08-23 复旦大学附属妇产科医院 一种用于预防子宫内膜异位症复发的腹腔冲洗液
RU2711615C1 (ru) * 2019-09-12 2020-01-17 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" Способ лечения эндометриоза на основании экспериментальной модели у крыс
AU2022217222A1 (en) * 2021-02-02 2023-08-10 Guangzhou Hutongyouwu Biotechnology Co., Ltd New use of pqq and derivative thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2227205C (en) 1995-07-21 2007-05-01 Constantia Gruppe Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
US20040122011A1 (en) 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
US7122203B2 (en) 2000-05-08 2006-10-17 Eli Lilly And Company Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
MY125009A (en) 2000-10-20 2006-07-31 Lilly Co Eli A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene hydrochloride
US20030190381A1 (en) 2001-02-02 2003-10-09 Bland Jeffrey S. Medical composition for balancing bodily processes
AU2004290585A1 (en) 2003-11-18 2005-06-02 Attenuon Llc Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
US20070287676A1 (en) 2006-05-16 2007-12-13 Sun-Wei Guo Diagnosis and treatment of endometriosis
EP2305238B1 (en) 2009-09-25 2011-12-14 Iasomai aktiebolag N-acetyl-L-cysteine for the treatment of endometriosis

Also Published As

Publication number Publication date
EP2305238B1 (en) 2011-12-14
AU2010299801B2 (en) 2016-06-30
CN106974900A (zh) 2017-07-25
WO2011036265A1 (en) 2011-03-31
AU2010299801A1 (en) 2012-04-19
RU2549433C2 (ru) 2015-04-27
US20120238627A1 (en) 2012-09-20
CN107007584A (zh) 2017-08-04
ES2382167T3 (es) 2012-06-06
EP2305238A1 (en) 2011-04-06
JP2013505916A (ja) 2013-02-21
US8637573B2 (en) 2014-01-28
DK2305238T3 (da) 2012-03-26
ATE536870T1 (de) 2011-12-15
RU2012116441A (ru) 2013-10-27
JP5699396B2 (ja) 2015-04-08
CN102665707A (zh) 2012-09-12

Similar Documents

Publication Publication Date Title
PL2305238T3 (pl) N-acetylo-L-cysteina do leczenia endometriozy
PH12012501067A1 (en) Combination therapy for treating cancer and diagnostic assays for use therein
WO2012071129A3 (en) Surgical implant
NZ717373A (en) The use of inhibitors of bruton’s tyrosine kinase (btk)
ATE553719T1 (de) Vorrichtung zur unterstützung eines vaginalcuffs
WO2012119146A3 (en) Anterior lesser tuberosity fixed angle fixation device and method of use associated therewith
IN2012DN06309A (pl)
MX2025000676A (es) Sistema de tratamiento de reflujo gastroesofagico mejorado, metodo, y dispositivo
FR2980967B1 (fr) Plaque d'osteosynthese pour une technique d'osteotomie tibiale de valgisation par addition interne
CY1110239T1 (el) Χρηση ακετυλο-l-kapnιτινη σε συνδυασμο με προπιονυλο-l-καρνιτινη και σιλδεναφιλη για τη θεραπευτικη αγωγη της στυτικης δυσλειτουργιας
RU2013151984A (ru) Способ лечения эссенциальной артериальной гипертензии на фоне ожирения
Lane PM401. NMDA-enhancing agents improve cognitive function of patients with schizophrenia
Giudice et al. Hydro-physiotherapy in the" downer cow" rehabilitation.
RU2009119225A (ru) Способ лечения и профилактики кокцидиозов норок
Fortuni Diarrhoea and incontinence: case report
Abaeva et al. FERMENTATIVNYE ASPEKTY PATOGENEZA PROLAPSA GENITALIY
Askhakov et al. The clinical case of Sneddon-Wilkinson disease in a pregnant woman
陳律文 et al. Anterior inferior iliac spine avulsion fracture in an adolescent runner: a case report
Walasik et al. APPLICATION OF SELECTED MANUAL THERAPY TECHNIQUES ACCORDING TO MULLIGAN CONCEPT IN PATIENTS WITH CERVICAL SPINE PAINS
Domazcii et al. DOGS AND CATS TOXOCARIASIS IN URBANFOCIOF WEST SIBERIA
UA45192U (ru) Способ определения риска развития атипичной трансформной гиперплазии эндометрия в перименопаузе у женщин с абдоминальным ожирением
Dal Moro et al. What is the impact on sexual function of POP surgery? Re: Cao Q, Chen YS, Ding JX et al. Long-term treatment outcomes of transvaginal mesh surgery versus anterior-posterior colporrhaphy for pelvic organ prolapse. Aust NZJ Obstet Gynaecol 2013; 53: 79-85
RU2011106428A (ru) Способ лечения больных генитальным эндометриозом с сопутствующим сколиозом
Griebling Re: Effect of Testosterone Administration on Liver Fat in Older Men with Mobility Limitation: Results from a Randomized Controlled Trial
Krishnappa et al. Turner Syndrome